Canaccord Genuity Maintains Buy on GH Research, Raises Price Target to $39
Benzinga Newsdesk 10 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Sumant Kulkarni maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $35 to $39.
Canaccord Genuity analyst Sumant Kulkarni maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $35 to $39.